In the rapidly evolving field of oncology, the development of advanced anti-tumor therapeutics continues to offer new hope for patients battling various forms of cancer. As global healthcare systems ...
Suggested remit: To appraise the clinical and cost effectiveness of glofitamab with gemcitabine and oxaliplatin within its marketing authorisation for treating relapsed or refractory diffuse large ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback